470 related articles for article (PubMed ID: 9761692)
1. Crystal structure of carbonic anhydrase from Neisseria gonorrhoeae and its complex with the inhibitor acetazolamide.
Huang S; Xue Y; Sauer-Eriksson E; Chirica L; Lindskog S; Jonsson BH
J Mol Biol; 1998; 283(1):301-10. PubMed ID: 9761692
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of human carbonic anhydrase XIII and its complex with the inhibitor acetazolamide.
Di Fiore A; Monti SM; Hilvo M; Parkkila S; Romano V; Scaloni A; Pedone C; Scozzafava A; Supuran CT; De Simone G
Proteins; 2009 Jan; 74(1):164-75. PubMed ID: 18618712
[TBL] [Abstract][Full Text] [Related]
3. Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II "selective" inhibitor celecoxib.
Di Fiore A; Pedone C; D'Ambrosio K; Scozzafava A; De Simone G; Supuran CT
Bioorg Med Chem Lett; 2006 Jan; 16(2):437-42. PubMed ID: 16290146
[TBL] [Abstract][Full Text] [Related]
4. Drug-protein interactions. Refined structures of three sulfonamide drug complexes of human carbonic anhydrase I enzyme.
Chakravarty S; Kannan KK
J Mol Biol; 1994 Oct; 243(2):298-309. PubMed ID: 7932756
[TBL] [Abstract][Full Text] [Related]
5. Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with a topically acting antiglaucoma sulfonamide.
Abbate F; Casini A; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2004 May; 14(9):2357-61. PubMed ID: 15081040
[TBL] [Abstract][Full Text] [Related]
6. Crystallographic studies of inhibitor binding sites in human carbonic anhydrase II: a pentacoordinated binding of the SCN- ion to the zinc at high pH.
Eriksson AE; Kylsten PM; Jones TA; Liljas A
Proteins; 1988; 4(4):283-93. PubMed ID: 3151020
[TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase inhibitors: X-ray crystallographic studies for the binding of 5-amino-1,3,4-thiadiazole-2-sulfonamide and 5-(4-amino-3-chloro-5-fluorophenylsulfonamido)-1,3,4-thiadiazole-2-sulfonamide to human isoform II.
Menchise V; De Simone G; Di Fiore A; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2006 Dec; 16(24):6204-8. PubMed ID: 17000110
[TBL] [Abstract][Full Text] [Related]
8. Carbonic anhydrase activators: X-ray crystal structure of the adduct of human isozyme II with L-histidine as a platform for the design of stronger activators.
Temperini C; Scozzafava A; Puccetti L; Supuran CT
Bioorg Med Chem Lett; 2005 Dec; 15(23):5136-41. PubMed ID: 16214338
[TBL] [Abstract][Full Text] [Related]
9. Refined structure of bovine carbonic anhydrase III at 2.0 A resolution.
Eriksson AE; Liljas A
Proteins; 1993 May; 16(1):29-42. PubMed ID: 8497481
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of the complex between human carbonic anhydrase II and the aromatic inhibitor 1,2,4-triazole.
Mangani S; Liljas A
J Mol Biol; 1993 Jul; 232(1):9-14. PubMed ID: 8331673
[TBL] [Abstract][Full Text] [Related]
11. Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: solution and X-ray crystallographic studies.
De Simone G; Di Fiore A; Menchise V; Pedone C; Antel J; Casini A; Scozzafava A; Wurl M; Supuran CT
Bioorg Med Chem Lett; 2005 May; 15(9):2315-20. PubMed ID: 15837316
[TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase activators. Activation of isozymes I, II, IV, VA, VII, and XIV with l- and d-histidine and crystallographic analysis of their adducts with isoform II: engineering proton-transfer processes within the active site of an enzyme.
Temperini C; Scozzafava A; Vullo D; Supuran CT
Chemistry; 2006 Sep; 12(27):7057-66. PubMed ID: 16807956
[TBL] [Abstract][Full Text] [Related]
13. Reversal of the hydrogen bond to zinc ligand histidine-119 dramatically diminishes catalysis and enhances metal equilibration kinetics in carbonic anhydrase II.
Huang CC; Lesburg CA; Kiefer LL; Fierke CA; Christianson DW
Biochemistry; 1996 Mar; 35(11):3439-46. PubMed ID: 8639494
[TBL] [Abstract][Full Text] [Related]
14. Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition.
Weber A; Casini A; Heine A; Kuhn D; Supuran CT; Scozzafava A; Klebe G
J Med Chem; 2004 Jan; 47(3):550-7. PubMed ID: 14736236
[TBL] [Abstract][Full Text] [Related]
15. Homology modeling and receptor-based 3D-QSAR study of carbonic anhydrase IX.
Tuccinardi T; Ortore G; Rossello A; Supuran CT; Martinelli A
J Chem Inf Model; 2007; 47(6):2253-62. PubMed ID: 17949069
[TBL] [Abstract][Full Text] [Related]
16. Conformational variability of different sulfonamide inhibitors with thienyl-acetamido moieties attributes to differential binding in the active site of cytosolic human carbonic anhydrase isoforms.
Biswas S; Aggarwal M; Güzel Ö; Scozzafava A; McKenna R; Supuran CT
Bioorg Med Chem; 2011 Jun; 19(12):3732-8. PubMed ID: 21620713
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of the soluble domain of the major anaerobically induced outer membrane protein (AniA) from pathogenic Neisseria: a new class of copper-containing nitrite reductases.
Boulanger MJ; Murphy ME
J Mol Biol; 2002 Feb; 315(5):1111-27. PubMed ID: 11827480
[TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase inhibitors: the X-ray crystal structure of the adduct of N-hydroxysulfamide with isozyme II explains why this new zinc binding function is effective in the design of potent inhibitors.
Temperini C; Winum JY; Montero JL; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2007 May; 17(10):2795-801. PubMed ID: 17346964
[TBL] [Abstract][Full Text] [Related]
19. Positions of His-64 and a bound water in human carbonic anhydrase II upon binding three structurally related inhibitors.
Smith GM; Alexander RS; Christianson DW; McKeever BM; Ponticello GS; Springer JP; Randall WC; Baldwin JJ; Habecker CN
Protein Sci; 1994 Jan; 3(1):118-25. PubMed ID: 8142888
[TBL] [Abstract][Full Text] [Related]
20. Carbonic anhydrase inhibitors: inhibition of human, bacterial, and archaeal isozymes with benzene-1,3-disulfonamides--solution and crystallographic studies.
Alterio V; De Simone G; Monti SM; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2007 Aug; 17(15):4201-7. PubMed ID: 17540563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
